Asymptomatic COVID-19 Individuals Tend to Establish Relatively Balanced Innate and Adaptive Immune Responses

被引:10
作者
Li, Miao [1 ]
Zhang, Yue [1 ]
Lu, Jianhua [2 ]
Li, Li [2 ]
Gao, Huixia [2 ]
Ma, Cuiqing [1 ]
Dai, Erhei [2 ]
Wei, Lin [1 ]
机构
[1] Hebei Med Univ, Dept Immunol, Key Lab Immune Mech & Intervent Serious Dis Hebei, Shijiazhuang 050000, Hebei, Peoples R China
[2] Hebei Med Univ, Hosp Shijiazhuang 5, Shijiazhuang 050000, Hebei, Peoples R China
关键词
asymptomatic; COVID-19; SARS-CoV-2; immune responses; T-CELL; TYPE-1; INFECTIONS; INHIBITOR;
D O I
10.3390/pathogens10091105
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The sharp increase in the proportion of asymptomatic cases and the potential risk of virus transmission have greatly increased the difficulty of controlling the COVID-19 pandemic. The individual immune response is closely associated with clinical outcomes and pathogenic mechanisms of COVID-19. However, the clinical characteristics and immunophenotyping features of immune cells of asymptomatic individuals remain somewhat mysterious. To better understand and predict the disease state and progress, we performed a comprehensive analysis of clinical data, laboratory indexes and immunophenotyping features in 41 patients with SARS-CoV-2 (including 24 asymptomatic cases and 17 symptomatic individuals). Firstly, from the perspective of demographic characteristics, the rate of asymptomatic infection was significantly higher in those with younger age. Secondly, the laboratory test results showed that some indexes, such as CRP (acute phase reaction protein), D-Dimer and fibrinogen (the marker for coagulation) were lower in the asymptomatic group. Finally, symptomatic individuals were prone to establishing a non-protective immune phenotype by abnormally decreasing the lymphocyte count and percentage, abnormally increasing the Th17 percentage and decreasing Treg percentage, which therefore cause an increase in the neutrophil/lymphocyte ratio (NLR), monocytes/lymphocytes ratio (MLR) and Th17/Treg ratio. On the other hand, asymptomatic individuals tended to establish a more effective and protective immune phenotype by maintaining a normal level of lymphocyte count and percentage and a high level of NK cells. At the same time, asymptomatic individuals can establish a relatively balanced immune response through maintaining a low level of monocytes, a relatively low level of Th17 and high level of Treg, which therefore lead to a decrease in MNKR and Th17/Treg ratio and finally the avoidance of excessive inflammatory responses. This may be one of the reasons for their asymptomatic states. This study is helpful to reveal the immunological characteristics of asymptomatic individuals, understand immune pathogenesis of COVID-19 and predict clinical outcomes more precisely. However, owing to small sample sizes, a future study with larger sample size is still warranted.
引用
收藏
页数:17
相关论文
共 48 条
[1]   An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses [J].
André, P ;
Groettrup, M ;
Klenerman, P ;
de Giuli, R ;
Booth, BL ;
Cerundolo, V ;
Bonneville, M ;
Jotereau, F ;
Zinkernagel, RM ;
Lotteau, V .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (22) :13120-13124
[2]   Presumed Asymptomatic Carrier Transmission of COVID-19 [J].
Bai, Yan ;
Yao, Lingsheng ;
Wei, Tao ;
Tian, Fei ;
Jin, Dong-Yan ;
Chen, Lijuan ;
Wang, Meiyun .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (14) :1406-1407
[3]   Natural killer (NK) cells prevent virus production in cell culture [J].
Baraz, L ;
Khazanov, E ;
Condiotti, R ;
Kotler, M ;
Nagler, A .
BONE MARROW TRANSPLANTATION, 1999, 24 (02) :179-189
[4]   Is asthma protective against COVID-19? [J].
Carli, Giulia ;
Cecchi, Lorenzo ;
Stebbing, Justin ;
Parronchi, Paola ;
Farsi, Alessandro .
ALLERGY, 2021, 76 (03) :866-868
[5]   Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases [J].
Carsetti, Rita ;
Zaffina, Salvatore ;
Mortari, Eva Piano ;
Terreri, Sara ;
Corrente, Francesco ;
Capponi, Claudia ;
Palomba, Patrizia ;
Mirabella, Mattia ;
Cascioli, Simona ;
Palange, Paolo ;
Cuccaro, Ilaria ;
Milito, Cinzia ;
Zumla, Alimuddin ;
Maeurer, Markus ;
Camisa, Vincenzo ;
Vinci, Maria Rosaria ;
Santoro, Annapaola ;
Cimini, Eleonora ;
Marchioni, Luisa ;
Nicastri, Emanuele ;
Palmieri, Fabrizio ;
Agrati, Chiara ;
Ippolito, Giuseppe ;
Porzio, Ottavia ;
Concato, Carlo ;
Muda, Andrea Onetti ;
Raponi, Massimiliano ;
Quintarelli, Concetta ;
Quinti, Isabella ;
Locatelli, Franco .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[6]   Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2 [J].
Chan, Yi-Hao ;
Fong, Siew-Wai ;
Poh, Chek-Meng ;
Carissimo, Guillaume ;
Yeo, Nicholas Kim-Wah ;
Amrun, Siti Naqiah ;
Goh, Yun Shan ;
Lim, Jackwee ;
Xu, Weili ;
Chee, Rhonda Sin-Ling ;
Torres-Ruesta, Anthony ;
Lee, Cheryl Yi-Pin ;
Tay, Matthew Zirui ;
Chang, Zi Wei ;
Lee, Wen-Hsin ;
Wang, Bei ;
Tan, Seow-Yen ;
Kalimuddin, Shirin ;
Young, Barnaby Edward ;
Leo, Yee-Sin ;
Wang, Cheng-, I ;
Lee, Bernett ;
Rotzschke, Olaf ;
Lye, David Chien ;
Renia, Laurent ;
Ng, Lisa F. P. .
EMBO MOLECULAR MEDICINE, 2021, 13 (06)
[7]   Technical Guidelines for COVID-19 Laboratory Testing [J].
CHINA CDC WEEKLY, 2020, 2 (19) :332-336
[8]   Disease-Promoting Effects of Type I Interferons in Viral, Bacterial, and Coinfections [J].
Davidson, Sophia ;
Maini, Mala K. ;
Wack, Andreas .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2015, 35 (04) :252-264
[9]   Age-dependent effects in the transmission and control of COVID-19 epidemics [J].
Davies, Nicholas G. ;
Klepac, Petra ;
Liu, Yang ;
Prem, Kiesha ;
Jit, Mark ;
Eggo, Rosalind M. .
NATURE MEDICINE, 2020, 26 (08) :1205-+
[10]   Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19) [J].
Diao, Bo ;
Wang, Chenhui ;
Tan, Yingjun ;
Chen, Xiewan ;
Liu, Ying ;
Ning, Lifen ;
Chen, Li ;
Li, Min ;
Liu, Yueping ;
Wang, Gang ;
Yuan, Zilin ;
Feng, Zeqing ;
Zhang, Yi ;
Wu, Yuzhang ;
Chen, Yongwen .
FRONTIERS IN IMMUNOLOGY, 2020, 11